VUNO will participate in Arab Health 2024, the Middle East’s largest medical device exhibition, in Dubai from Jan. 29 to Feb. 1.At Arab Health 2024, VUNO will showcase its five key medical imaging and vital signs products. They are VUNO Med-Deep Brain, VUNO Med-Chest CT AI, VUNO Med-Chest X-ray, VUN
Ildong Pharmaceutical improved its profitability in the company’s performance results for 2023.Ildong Pharm disclosed its preliminary performance results for 2023 through a public announcement on Monday. The bottom lines showed that the company showed positive changes in operating income and net inc
Eighty-six percent of medical residents and interns will participate in collective action if the government increases the medical school enrollment quota, according to a survey released by the Korean Intern Resident Association (KIRA).However, the Korean Medical Association (KMA) declined to comment
Severance Hospital has developed an artificial intelligence (AI) model capable of rapidly and accurately diagnosing sepsis and predicting patient outcomes.Sepsis, a critical condition resulting from an abnormal body response to infection leading to major organ dysfunction, has high incidence and mor
Omni C&S, a Korean digital healthcare company, said Tuesday that it has received marketing authorization from the Thailand Food and Drug Administration for its electroencephalogram (EEG) and photoplethysmography (PPG) measurement device, Omnifit Mindcare.Omnifit Mindcare measures EEG and PPG to prov
Precision Biosensor, a Kosdaq-listed clinical diagnostics company, said Tuesday that it received marketing approval for two thyroid function hormone test reagents, Exdia TSH and Exdia fT4, from the Ministry of Food and Drug Safety (MFDS).Exdia TSH and Exdia fT4 can be easily used in hospitals to obt
AriBio, primarily known for its work to develop an oral Alzheimer's disease treatment candidate, has been penalized for the sale of cosmetics containing ingredients that are not permitted for use.The Ministry of Food and Drug Safety issued the penalty last Thursday, mandating a three-month suspensio
Samsung Bioepis, a subsidiary of Samsung Biologics, said it has received product approval from the Ministry of Food and Drug Safety for Epiruscly, a biosimilar referencing Soliris, last Friday.Soliris, developed by AstraZeneca's subsidiary Alexion Pharmaceuticals, is a high-cost biopharmaceutical fo
AbClon said Monday that AC101 (HLX in Chinese code name), licensed to Shanghai Henlius Biotech, has demonstrated potential as a first-line treatment for patients with HER2-positive gastric cancer in a phase 2 clinical trial.Henlius released interim results from the ongoing phase 2 clinical trial of
A research team at the Korea Institute of Science and Technology (KIST), in partnership with Seoul National University (SNU) and Kyung Hee University, developed a new drug delivery system that could better treat retinal diseases.Retinal diseases, such as age-related macular degeneration and retiniti
An aging society is one in which the share of people aged 65 or older accounts for 7 percent or more of the total population. If the comparable share reaches 14 percent, it is classified as an aged society, and if it exceeds 20 percent, it is labeled as a superaged society. Korea is one of the count
Merck Korea said it launched its Fertility Benefit Program for its employees and their spouses, effective from Jan. 1 this year.Merck Korea has about 1,750 employees, according to its website. The program, part of Merck's broader initiative "Fertility Counts," is designed to support the reproductive
Hanmi Pharm said that its combination antihypertensive drug, Amosartan Tab, has recorded cumulative sales of 1.05 trillion won ($786.2 million) as of December last year. The record was achieved more than 14 years after its launch, with sales averaging 75 billion won per year.Amosartan is a drug that
Since the Supreme Court ruled in favor of allowing the use of ultrasound diagnostic devices by oriental medicine practitioners, some companies, including GE Healthcare, have been selling their products to oriental medicine doctors.However, Samsung Medison and other companies are showing a contradict
The Health Insurance Review and Assessment Service (HIRA) recently hit back against criticism about the delayed reimbursement process for new drugs, including Enhertu and Ilaris.HIRA issued a news release last Wednesday, rebutting some media reports that the government's lukewarm attitude is delayin
NeoImmuneTech, a Kosdaq-listed T-cell-based immunotherapy developer, said Monday that its pancreatic cancer drug, NT-I7 (efineptakin alfa), has received an orphan drug designation (ODD) from the U.S. FDA.The FDA's ODD system is designed to facilitate the development and approval of drugs to treat ra
LifeSemantics, a digital health platform provider, said Monday that it would release the confirmatory clinical trial results of its home blood pressure prediction software (SW) in March.LifeSemantics initiated the confirmatory clinical trial on July 6 of last year and concluded the final patient enr
Lotte Biologics said it has entered into a strategic partnership with NJ Bio, a U.S. contract research organization (CRO), to enhance antibody-drug conjugate (ADC) services.Established in 2018 and based in New Jersey, NJ Bio specializes in integrated chemical and biological services for linker paylo
Samsung Biologics said Monday that it has been awarded the Platinum medal, the highest rating awarded to only the top 1 percent of companies worldwide, in the ESG assessment by global sustainability research organization EcoVadis.After achieving a Gold rating in 2022, Samsung Biologics moved up a no
Korea is currently facing a significant ethical and legal dilemma in its medical sector due to increasing instances of doctors performing surgeries while under the influence of alcohol.This issue gained national attention following an incident in January, where a young surgeon in Seoul conducted fac